Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection (original) (raw)
Clindamycin, Cephalosporins, Fluoroquinolones, and Clostridium difficile –Associated Diarrhea: This Is an Antimicrobial Resistance Problem
Dale Gerding
Clinical Infectious Diseases, 2004
View PDFchevron_right
Emergence and Control of Fluoroquinolone‐Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile •
Margaret Hannan
Infection Control and Hospital Epidemiology, 2007
View PDFchevron_right
818 @BULLET CID 2008:47 (15 September) @BULLET BRIEF REPORT High Levels of Resistance to Fluoroquinolones among Clostridium difficile Isolates in a Spanish Hospital
mar ss
View PDFchevron_right
Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové
Roman Spanek
Antibiotics, 2021
View PDFchevron_right
A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use
Marian Pokrywka
Infection Control & Hospital Epidemiology, 2005
View PDFchevron_right
Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones
Roslyn Stone
2008
View PDFchevron_right
Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital
Riaz Khan
Journal of Hospital Infection, 2003
View PDFchevron_right
Antibiotic-associated diarrhoea and Clostridium difficile> in the community
Michel Cadilhac
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Poor Infection Control, Not Fluoroquinolones, Likely to Be Primary Cause of Clostridium difficile-Associated Diarrhea Outbreaks in Quebec
Karl Weiss
Clinical Infectious Diseases, 2006
View PDFchevron_right
Antimicrobial Agents and Clostridium difficile in Acute Enteric Disease: Epidemiological Data from Sweden, 1980-1982
Roland Möllby
Journal of Infectious Diseases, 1985
View PDFchevron_right
Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich
Orville Heslop
BMC Infectious Diseases, 2014
View PDFchevron_right
Clostridium difficile virulence factors as the cause of antibiotic-associated diarrhea (AAD): a literature review
Agus Darwinata
Bali Medical Journal, 2022
View PDFchevron_right
Risk factors for Clostridium difficile colonisation and toxin production
HEATHER MARTIN
Age and Ageing, 2003
View PDFchevron_right
Clostridium difficile 30 years on: what has, or has not, changed and why?
Dale Gerding
International Journal of Antimicrobial Agents, 2009
View PDFchevron_right
Fluoroquinolone Use and Risk Factors for Clostridium difficile-Associated Disease within a Veterans Administration Health Care System
HENRY BENEDA
Clinical Infectious Diseases, 2007
View PDFchevron_right
In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004
Dale Gerding
Antimicrobial Agents and Chemotherapy, 2007
View PDFchevron_right
2007. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice. Antimicrob. Agents Chemother
Curtis Donskey
2015
View PDFchevron_right
Clostridium difficile: A Growing Health Concern
Anindita Pal
Journal of Advanced Scientific Research, 2019
View PDFchevron_right
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile
Dale Gerding
Journal of Hospital Infection, 2009
View PDFchevron_right
Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options
Saeed Nazeri
Scientifica, 2014
View PDFchevron_right
Temporal effects of antibiotic use and Clostridium difficile infections
Peter Davey
Journal of …, 2009
View PDFchevron_right
Corelations Between the Use of Medical Substances and the Incidence Infections Produced by Clostridium Difficile Species
Moldovan Cosmin
Revista de Chimie, 2018
View PDFchevron_right
Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile
Joseph Silva
Clinical Microbiology and Infection, 2003
View PDFchevron_right
Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital
Ainsley Nicholson
Infection Control and Hospital Epidemiology, 2009
View PDFchevron_right
Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model
Jane Freeman
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance
Minh Đăng TMĐ
Expert Review of Anti-infective Therapy, 2010
View PDFchevron_right
Increased Incidence of Clostridium difficile-Associated Diarrhea Following Decreased Restriction of Antibiotic Use
Macy Ho
Clinical Infectious Diseases, 1996
View PDFchevron_right
Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre
Rakesh Kochhar
The Indian journal of medical research, 2017
View PDFchevron_right
Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile
Gilles Potel
Microbial Ecology, 2008
View PDFchevron_right
Barrier Effect of Normal Microbiota Against Clostridium difficile may be Influenced by Drugs Devoid of Antibiotic Activity
Tuomo Karjalainen
Microbial Ecology in Health and Disease, 1994
View PDFchevron_right
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Sandra Dial
Canadian Medical Association Journal, 2008
View PDFchevron_right
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe
F. Barbut, Ian Poxton
Journal of Medical Microbiology, 2008
View PDFchevron_right
Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration
Michelle Merrigan
Anaerobe, 2003
View PDFchevron_right
Spore Production of Toxigenic and Non-toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime
mohammad moradi
Jundishapur Journal of Microbiology, 2019
View PDFchevron_right
Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo
Anne Collignon
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right